James B. Bliska - Publications

Affiliations: 
Stony Brook University, Stony Brook, NY, United States 
Area:
Microbiology

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Loeven NA, Reuven AD, McGee AP, Dabi C, Mwaura BW, Bliska JB. A Type VI Secretion System in Species and Triggers Distinct Macrophage Death Pathways Independent of the Pyrin Inflammasome. Biorxiv : the Preprint Server For Biology. PMID 38826213 DOI: 10.1101/2023.09.28.559184  0.325
2024 Reuven AD, Mwaura BW, Bliska JB. ExoS Effector in Hyperactive Type III Secretion System Mutant Promotes Enhanced Plasma Membrane Rupture in Neutrophils. Biorxiv : the Preprint Server For Biology. PMID 38328038 DOI: 10.1101/2024.01.24.577040  0.348
2022 Oh C, Li L, Verma A, Reuven AD, Miao EA, Bliska JB, Aachoui Y. Neutrophil inflammasomes sense the subcellular delivery route of translocated bacterial effectors and toxins. Cell Reports. 41: 111688. PMID 36417874 DOI: 10.1016/j.celrep.2022.111688  0.317
2021 Bliska JB, Brodsky IE, Mecsas J. Role of the Yersinia pseudotuberculosis Virulence Plasmid in Pathogen-Phagocyte Interactions in Mesenteric Lymph Nodes. Ecosal Plus. 9: eESP00142021. PMID 34910573 DOI: 10.1128/ecosalplus.ESP-0014-2021  0.368
2020 Malik HS, Bliska JB. The pyrin inflammasome and the Yersinia effector interaction. Immunological Reviews. PMID 32721043 DOI: 10.1111/Imr.12907  0.408
2020 Park YH, Remmers EF, Lee W, Ombrello AK, Chung LK, Shilei Z, Stone DL, Ivanov MI, Loeven NA, Barron KS, Hoffmann P, Nehrebecky M, Akkaya-Ulum YZ, Sag E, Balci-Peynircioglu B, ... ... Bliska JB, et al. Ancient familial Mediterranean fever mutations in human pyrin and resistance to Yersinia pestis. Nature Immunology. PMID 32601469 DOI: 10.1038/S41590-020-0705-6  0.317
2020 Loeven NA, Medici NP, Bliska JB. The pyrin inflammasome in host-microbe interactions. Current Opinion in Microbiology. 54: 77-86. PMID 32120337 DOI: 10.1016/J.Mib.2020.01.005  0.452
2019 McLaughlin PA, Bettke JA, Tam JW, Leeds J, Bliska JB, Butler BP, van der Velden AWM. Inflammatory monocytes provide a niche for Salmonella expansion in the lumen of the inflamed intestine. Plos Pathogens. 15: e1007847. PMID 31306468 DOI: 10.1371/Journal.Ppat.1007847  0.369
2019 Medici NP, Bliska JB. Methods for Detection of Pyrin Inflammasome Assembly in Macrophages Infected with Yersinia spp. Methods in Molecular Biology (Clifton, N.J.). 2010: 241-255. PMID 31177443 DOI: 10.1007/978-1-4939-9541-7_17  0.485
2019 Medici NP, Rashid M, Bliska JB. Characterization of pyrin dephosphorylation and inflammasome activation in macrophages as triggered by the effectors YopE and YopT. Infection and Immunity. PMID 30602502 DOI: 10.1128/Iai.00822-18  0.54
2018 Fukuto HS, Vadyvaloo V, McPhee JB, Poinar HN, Holmes EC, Bliska JB. A single amino acid change in the response regulator PhoP acquired duringevolution affects PhoP target gene transcription and polymyxin B susceptibility. Journal of Bacteriology. PMID 29440252 DOI: 10.1128/Jb.00050-18  0.385
2017 Zhang Y, Khairallah C, Sheridan BS, van der Velden AWM, Bliska JB. CCR2+ inflammatory monocytes are recruited to Yersinia pyogranulomas and dictate adaptive responses at the expense of innate immunity during oral infection. Infection and Immunity. PMID 29263104 DOI: 10.1128/Iai.00782-17  0.385
2017 Kim J, Fukuto HS, Brown DA, Bliska JB, London E. Effects of host cell sterol composition upon internalization of Yersinia pseudotuberculosis and clustered beta-1 integrin. The Journal of Biological Chemistry. PMID 29197826 DOI: 10.1074/Jbc.M117.811224  0.442
2017 Zwack EE, Feeley E, Burton AR, Hu B, Yamamoto M, Kanneganti TD, Bliska JB, Coers J, Brodsky IE. Guanylate Binding Proteins regulate inflammasome activation in response to hyper-injected Yersinia translocon components. Infection and Immunity. PMID 28784930 DOI: 10.1128/Iai.00778-16  0.449
2017 Kim J, Fukuto HS, Bliska JB, London E. Effects of Sterol Substitution in Plasma Membrane of Host Cell upon Internalization of Yersinia Pseudotuberculosis Biophysical Journal. 112: 92a. DOI: 10.1016/J.Bpj.2016.11.539  0.386
2016 Chung LK, Park YH, Zheng Y, Brodsky IE, Hearing P, Kastner DL, Chae JJ, Bliska JB. The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome. Cell Host & Microbe. PMID 27569559 DOI: 10.1016/J.Chom.2016.07.018  0.507
2016 Schoberle TJ, Chung LK, McPhee JB, Bogin B, Bliska JB. Uncovering an Important Role for YopJ in the Inhibition of Caspase-1 in Activated Macrophages and Promoting Yersinia pseudotuberculosis Virulence. Infection and Immunity. PMID 26810037 DOI: 10.1128/Iai.00843-15  0.496
2015 Chung LK, Bliska JB. Yersinia versus host immunity: how a pathogen evades or triggers a protective response. Current Opinion in Microbiology. 29: 56-62. PMID 26638030 DOI: 10.1016/J.Mib.2015.11.001  0.405
2015 Zhang Y, Tam JW, Mena P, van der Velden AW, Bliska JB. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection. Plos Pathogens. 11: e1005167. PMID 26468944 DOI: 10.1371/Journal.Ppat.1005167  0.358
2015 Solomon R, Zhang W, McCrann G, Bliska JB, Viboud GI. Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function. Plos One. 10: e0120471. PMID 25807250 DOI: 10.1371/Journal.Pone.0120471  0.469
2015 Zwack EE, Snyder AG, Wynosky-Dolfi MA, Ruthel G, Philip NH, Marketon MM, Francis MS, Bliska JB, Brodsky IE. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD. Mbio. 6: e02095-14. PMID 25691590 DOI: 10.1128/Mbio.02095-14  0.418
2014 Wang X, Parashar K, Sitaram A, Bliska JB. The GAP activity of type III effector YopE triggers killing of Yersinia in macrophages. Plos Pathogens. 10: e1004346. PMID 25165815 DOI: 10.1371/journal.ppat.1004346  0.444
2014 Chung LK, Philip NH, Schmidt VA, Koller A, Strowig T, Flavell RA, Brodsky IE, Bliska JB. IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM. Mbio. 5: e01402-14. PMID 24987096 DOI: 10.1128/Mbio.01402-14  0.398
2014 Bublitz DC, Wright PC, Bodager JR, Rasambainarivo FT, Bliska JB, Gillespie TR. Epidemiology of pathogenic enterobacteria in humans, livestock, and peridomestic rodents in rural Madagascar. Plos One. 9: e101456. PMID 24983990 DOI: 10.1371/Journal.Pone.0101456  0.347
2014 Szaba FM, Kummer LW, Duso DK, Koroleva EP, Tumanov AV, Cooper AM, Bliska JB, Smiley ST, Lin JS. TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection. Plos Pathogens. 10: e1004142. PMID 24854422 DOI: 10.1371/Journal.Ppat.1004142  0.341
2014 Rüter C, Silva MR, Grabowski B, Lubos ML, Scharnert J, Poceva M, von Tils D, Flieger A, Heesemann J, Bliska JB, Schmidt MA. Rabbit monoclonal antibodies directed at the T3SS effector protein YopM identify human pathogenic Yersinia isolates. International Journal of Medical Microbiology : Ijmm. 304: 444-51. PMID 24636859 DOI: 10.1016/J.Ijmm.2014.02.003  0.408
2014 Ivanov MI, Hill J, Bliska JB. Direct neutralization of type III effector translocation by the variable region of a monoclonal antibody to Yersinia pestis LcrV. Clinical and Vaccine Immunology : Cvi. 21: 667-73. PMID 24599533 DOI: 10.1128/CVI.00013-14  0.329
2013 Bliska JB, Wang X, Viboud GI, Brodsky IE. Modulation of innate immune responses by Yersinia type III secretion system translocators and effectors. Cellular Microbiology. 15: 1622-31. PMID 23834311 DOI: 10.1111/Cmi.12164  0.421
2012 Bliska JB, van der Velden AW. Salmonella "sops" up a preferred electron receptor in the inflamed intestine. Mbio. 3: e00226-12. PMID 22893385 DOI: 10.1128/Mbio.00226-12  0.388
2012 Hatkoff M, Runco LM, Pujol C, Jayatilaka I, Furie MB, Bliska JB, Thanassi DG. Roles of chaperone/usher pathways of Yersinia pestis in a murine model of plague and adhesion to host cells. Infection and Immunity. 80: 3490-500. PMID 22851745 DOI: 10.1128/Iai.00434-12  0.429
2012 Zheng Y, Lilo S, Mena P, Bliska JB. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense. Plos One. 7: e36019. PMID 22563435 DOI: 10.1371/Journal.Pone.0036019  0.81
2012 McPhee JB, Mena P, Zhang Y, Bliska JB. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM. Infection and Immunity. 80: 2519-27. PMID 22547545 DOI: 10.1128/Iai.06364-11  0.405
2012 Thanassi DG, Bliska JB, Christie PJ. Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function. Fems Microbiology Reviews. 36: 1046-82. PMID 22545799 DOI: 10.1111/J.1574-6976.2012.00342.X  0.358
2012 Torres R, Chim N, Sankaran B, Pujol C, Bliska JB, Goulding CW. Structural insights into RipC, a putative citrate lyase β subunit from a Yersinia pestis virulence operon. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 68: 2-7. PMID 22232161 DOI: 10.1107/S1744309111048056  0.318
2012 Klein KA, Fukuto HS, Pelletier M, Romanov G, Grabenstein JP, Palmer LE, Ernst R, Bliska JB. A transposon site hybridization screen identifies galU and wecBC as important for survival of Yersinia pestis in murine macrophages. Journal of Bacteriology. 194: 653-62. PMID 22139502 DOI: 10.1128/Jb.06237-11  0.77
2012 Zhang Y, Mena P, Romanov G, Lin JS, Smiley ST, Bliska JB. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis. Infection and Immunity. 80: 206-14. PMID 22064714 DOI: 10.1128/Iai.05971-11  0.374
2011 Torres R, Swift RV, Chim N, Wheatley N, Lan B, Atwood BR, Pujol C, Sankaran B, Bliska JB, Amaro RE, Goulding CW. Biochemical, structural and molecular dynamics analyses of the potential virulence factor RipA from Yersinia pestis. Plos One. 6: e25084. PMID 21966419 DOI: 10.1371/Journal.Pone.0025084  0.355
2011 Zhang Y, Romanov G, Bliska JB. Type III secretion system-dependent translocation of ectopically expressed Yop effectors into macrophages by intracellular Yersinia pseudotuberculosis. Infection and Immunity. 79: 4322-31. PMID 21844228 DOI: 10.1128/Iai.05396-11  0.541
2011 Zheng Y, Lilo S, Brodsky IE, Zhang Y, Medzhitov R, Marcu KB, Bliska JB. A Yersinia effector with enhanced inhibitory activity on the NF-κB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. Plos Pathogens. 7: e1002026. PMID 21533069 DOI: 10.1371/Journal.Ppat.1002026  0.813
2011 Zhang Y, Bliska JB. Mathematical relationship between cytokine concentrations and pathogen levels during infection. Cytokine. 53: 158-62. PMID 21093285 DOI: 10.1016/J.Cyto.2010.09.008  0.403
2010 Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine. 29: 357-62. PMID 20840834 DOI: 10.1016/J.Vaccine.2010.08.099  0.367
2010 Fukuto HS, Svetlanov A, Palmer LE, Karzai AW, Bliska JB. Global gene expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative stress-induced operon in regulating type III secretion and intracellular cell division. Infection and Immunity. 78: 3700-15. PMID 20566693 DOI: 10.1128/Iai.00062-10  0.454
2010 McPhee JB, Mena P, Bliska JB. Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence. Infection and Immunity. 78: 3529-39. PMID 20515922 DOI: 10.1128/Iai.00269-10  0.449
2010 Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, Flavell RA, Bliska JB, Medzhitov R. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host & Microbe. 7: 376-87. PMID 20478539 DOI: 10.1016/J.Chom.2010.04.009  0.799
2010 Zhang Y, Bliska JB. YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infection and Immunity. 78: 2329-41. PMID 20231414 DOI: 10.1128/Iai.00094-10  0.396
2010 Okan NA, Mena P, Benach JL, Bliska JB, Karzai AW. The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infection. Infection and Immunity. 78: 1284-93. PMID 20065026 DOI: 10.1128/Iai.00976-09  0.38
2009 Noel BL, Lilo S, Capurso D, Hill J, Bliska JB. Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages. Clinical and Vaccine Immunology : Cvi. 16: 1457-66. PMID 19710295 DOI: 10.1128/Cvi.00172-09  0.772
2009 Klein KA, Bliska JB. How Yersinia pestis becomes a foreign obstruction in the digestive system of the macrophage. Autophagy. 5: 882-3. PMID 19550144 DOI: 10.4161/Auto.9095  0.721
2009 Pujol C, Klein KA, Romanov GA, Palmer LE, Cirota C, Zhao Z, Bliska JB. Yersinia pestis can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification. Infection and Immunity. 77: 2251-61. PMID 19289509 DOI: 10.1128/Iai.00068-09  0.725
2009 Bliska JB, Casadevall A. Intracellular pathogenic bacteria and fungi--a case of convergent evolution? Nature Reviews. Microbiology. 7: 165-71. PMID 19098923 DOI: 10.1038/Nrmicro2049  0.375
2008 Ivanov MI, Noel BL, Rampersaud R, Mena P, Benach JL, Bliska JB. Vaccination of mice with a Yop translocon complex elicits antibodies that are protective against infection with F1- Yersinia pestis. Infection and Immunity. 76: 5181-90. PMID 18765742 DOI: 10.1128/Iai.00189-08  0.762
2008 Zhang Y, Murtha J, Roberts MA, Siegel RM, Bliska JB. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages. Infection and Immunity. 76: 4299-310. PMID 18591234 DOI: 10.1128/Iai.00183-08  0.562
2008 Lilo S, Zheng Y, Bliska JB. Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. Infection and Immunity. 76: 3911-23. PMID 18559430 DOI: 10.1128/Iai.01695-07  0.808
2008 Mejía E, Bliska JB, Viboud GI. Yersinia controls type III effector delivery into host cells by modulating Rho activity. Plos Pathogens. 4: e3. PMID 18193942 DOI: 10.1371/Journal.Ppat.0040003  0.434
2006 Bliska JB. Yersinia inhibits host signaling by acetylating MAPK kinases. Acs Chemical Biology. 1: 349-51. PMID 17163770 DOI: 10.1021/Cb600261K  0.42
2006 Prehna G, Ivanov MI, Bliska JB, Stebbins CE. Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors. Cell. 126: 869-80. PMID 16959567 DOI: 10.1016/J.Cell.2006.06.056  0.474
2006 Viboud GI, Mejía E, Bliska JB. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection. Cellular Microbiology. 8: 1504-15. PMID 16922868 DOI: 10.1111/J.1462-5822.2006.00729.X  0.398
2006 Grabenstein JP, Fukuto HS, Palmer LE, Bliska JB. Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of Yersinia pestis in macrophages. Infection and Immunity. 74: 3727-41. PMID 16790745 DOI: 10.1128/Iai.00255-06  0.799
2006 Okan NA, Bliska JB, Karzai AW. A Role for the SmpB-SsrA system in Yersinia pseudotuberculosis pathogenesis. Plos Pathogens. 2: e6. PMID 16450010 DOI: 10.1371/Journal.Ppat.0020006  0.466
2006 Bliska JB, Ryndak MB, Grabenstein JP. Type III secretion systems in yersinia pestis and yersinia pseudotuberculosis Bacterial Genomes and Infectious Diseases. 213-226. DOI: 10.1007/978-1-59745-152-9_12  0.735
2005 Hudson KJ, Bliska JB, Bouton AH. Distinct mechanisms of integrin binding by Yersinia pseudotuberculosis adhesins determine the phagocytic response of host macrophages. Cellular Microbiology. 7: 1474-89. PMID 16153246 DOI: 10.1111/J.1462-5822.2005.00571.X  0.402
2005 Pujol C, Grabenstein JP, Perry RD, Bliska JB. Replication of Yersinia pestis in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus. Proceedings of the National Academy of Sciences of the United States of America. 102: 12909-14. PMID 16120681 DOI: 10.1073/Pnas.0502849102  0.793
2005 Zhang Y, Ting AT, Marcu KB, Bliska JB. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. Journal of Immunology (Baltimore, Md. : 1950). 174: 7939-49. PMID 15944300 DOI: 10.4049/Jimmunol.174.12.7939  0.426
2005 Viboud GI, Bliska JB. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annual Review of Microbiology. 59: 69-89. PMID 15847602 DOI: 10.1146/Annurev.Micro.59.030804.121320  0.466
2005 Zhang Y, Bliska JB. Role of macrophage apoptosis in the pathogenesis of Yersinia Current Topics in Microbiology and Immunology. 289: 151-173. PMID 15791955 DOI: 10.1007/3-540-27320-4_7  0.472
2005 Ryndak MB, Chung H, London E, Bliska JB. Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein. Infection and Immunity. 73: 2433-43. PMID 15784589 DOI: 10.1128/Iai.73.4.2433-2443.2005  0.785
2005 Pujol C, Bliska JB. Turning Yersinia pathogenesis outside in: subversion of macrophage function by intracellular yersiniae. Clinical Immunology (Orlando, Fla.). 114: 216-26. PMID 15721832 DOI: 10.1016/J.Clim.2004.07.013  0.504
2005 Ivanov MI, Stuckey JA, Schubert HL, Saper MA, Bliska JB. Two substrate-targeting sites in the Yersinia protein tyrosine phosphatase co-operate to promote bacterial virulence. Molecular Microbiology. 55: 1346-56. PMID 15720545 DOI: 10.1111/J.1365-2958.2005.04477.X  0.416
2004 Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infection and Immunity. 72: 4973-84. PMID 15321989 DOI: 10.1128/Iai.72.9.4973-4984.2004  0.797
2004 Roy D, Liston DR, Idone VJ, Di A, Nelson DJ, Pujol C, Bliska JB, Chakrabarti S, Andrews NW. A process for controlling intracellular bacterial infections induced by membrane injury. Science (New York, N.Y.). 304: 1515-8. PMID 15178804 DOI: 10.1126/Science.1098371  0.371
2003 Pujol C, Bliska JB. The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infection and Immunity. 71: 5892-9. PMID 14500510 DOI: 10.1128/Iai.71.10.5892-5899.2003  0.435
2003 Liang F, Huang Z, Lee SY, Liang J, Ivanov MI, Alonso A, Bliska JB, Lawrence DS, Mustelin T, Zhang ZY. Aurintricarboxylic acid blocks in vitro and in vivo activity of YopH, an essential virulent factor of Yersinia pestis, the agent of plague. The Journal of Biological Chemistry. 278: 41734-41. PMID 12888560 DOI: 10.1074/Jbc.M307152200  0.359
2003 McDonald C, Vacratsis PO, Bliska JB, Dixon JE. The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. The Journal of Biological Chemistry. 278: 18514-23. PMID 12626518 DOI: 10.1074/Jbc.M301226200  0.314
2003 Viboud GI, So SS, Ryndak MB, Bliska JB. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis. Molecular Microbiology. 47: 1305-15. PMID 12603736 DOI: 10.1046/J.1365-2958.2003.03350.X  0.79
2003 Zhang Y, Bliska JB. Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infection and Immunity. 71: 1513-9. PMID 12595470 DOI: 10.1128/Iai.71.3.1513-1519.2003  0.441
2002 Viboud GI, Bliska JB. Measurement of pore formation by contact-dependent type III protein secretion systems. Methods in Enzymology. 358: 345-50. PMID 12474398 DOI: 10.1016/S0076-6879(02)58100-3  0.358
2002 Orth K, Dixon JE, Bliska JB. 20 Effector proteins of bacterial type III protein secretion systems: Elucidating their biochemical effects on eukaryotic signaling cascades Methods in Microbiology. 31: 361-376. DOI: 10.1016/S0580-9517(02)31021-3  0.414
2001 Viboud GI, Bliska JB. A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes Embo Journal. 20: 5373-5382. PMID 11574469 DOI: 10.1093/Emboj/20.19.5373  0.432
2001 Montagna LG, Ivanov MI, Bliska JB. Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition. The Journal of Biological Chemistry. 276: 5005-11. PMID 11069923 DOI: 10.1074/Jbc.M009045200  0.762
2000 Weidow CL, Black DS, Bliska JB, Bouton AH. CAS/Crk signalling mediates uptake of Yersinia into human epithelial cells. Cellular Microbiology. 2: 549-60. PMID 11207607 DOI: 10.1046/J.1462-5822.2000.00079.X  0.375
2000 Black DS, Marie-Cardine A, Schraven B, Bliska JB. The Yersinia tyrosine phosphatase YopH targets a novel adhesion-regulated signalling complex in macrophages. Cellular Microbiology. 2: 401-14. PMID 11207596 DOI: 10.1046/J.1462-5822.2000.00061.X  0.447
2000 Black DS, Bliska JB. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Molecular Microbiology. 37: 515-27. PMID 10931345 DOI: 10.1046/J.1365-2958.2000.02021.X  0.459
1999 Orth K, Palmer LE, Bao ZQ, Stewart S, Rudolph AE, Bliska JB, Dixon JE. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector Science. 285: 1920-1923. PMID 10489373 DOI: 10.1126/Science.285.5435.1920  0.414
1999 Palmer LE, Pancetti AR, Greenberg S, Bliska JB. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells Infection and Immunity. 67: 708-716. PMID 9916081 DOI: 10.1128/Iai.67.2.708-716.1999  0.423
1998 Black DS, Montagna LG, Zitsmann S, Bliska JB. Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets. Molecular Microbiology. 29: 1263-74. PMID 9767593 DOI: 10.1046/J.1365-2958.1998.01014.X  0.753
1998 Palmer LE, Hobble S, Galán JE, Bliska JB. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-α production and downregulation of the MAP kinases p38 and JNK Molecular Microbiology. 27: 953-965. PMID 9535085 DOI: 10.1046/J.1365-2958.1998.00740.X  0.398
1997 Black DS, Bliska JB. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. The Embo Journal. 16: 2730-44. PMID 9184219 DOI: 10.1093/Emboj/16.10.2730  0.436
1996 Galán JE, Bliska JB. Cross-talk between bacterial pathogens and their host cells Annual Review of Cell and Developmental Biology. 12: 221-255. PMID 8970727 DOI: 10.1146/Annurev.Cellbio.12.1.221  0.416
1996 Kaniga K, Uralil J, Bliska JB, Galán JE. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium Molecular Microbiology. 21: 633-641. PMID 8866485 DOI: 10.1111/J.1365-2958.1996.Tb02571.X  0.462
1996 Bliska J. How pathogens exploit interactions mediated by SH3 domains Chemistry and Biology. 3: 7-11. PMID 8807821 DOI: 10.1016/S1074-5521(96)90076-9  0.408
1995 Bliska JB, Black DS. Inhibition of the Fc receptor-mediated oxidative burst in macrophages by the Yersinia pseudotuberculosis tyrosine phosphatase. Infection and Immunity. 63: 681-5. PMID 7822039 DOI: 10.1128/Iai.63.2.681-685.1995  0.471
1993 Bliska JB, Galán JE, Falkow S. Signal transduction in the mammalian cell during bacterial attachment and entry. Cell. 73: 903-20. PMID 8500180 DOI: 10.1016/0092-8674(93)90270-Z  0.313
1993 Bliska JB, Falkow S. The role of host tyrosine phosphorylation in bacterial pathogenesis. Trends in Genetics : Tig. 9: 85-9. PMID 8488567 DOI: 10.1016/0168-9525(93)90229-B  0.419
1993 Bliska JB, Copass MC, Falkow S. The Yersinia pseudotuberculosis adhesin YadA mediates intimate bacterial attachment to and entry into HEp-2 cells. Infection and Immunity. 61: 3914-21. PMID 7689542  0.338
1992 Bliska JB, Falkow S. Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica. Proceedings of the National Academy of Sciences of the United States of America. 89: 3561-5. PMID 1565652 DOI: 10.1073/Pnas.89.8.3561  0.394
1992 Bliska JB, Clemens JC, Dixon JE, Falkow S. The Yersinia tyrosine phosphatase: specificity of a bacterial virulence determinant for phosphoproteins in the J774A.1 macrophage. The Journal of Experimental Medicine. 176: 1625-30. PMID 1281213 DOI: 10.1084/Jem.176.6.1625  0.462
1991 Clemens JC, Guan K, Bliska JB, Falkow S, Dixon JE. Microbial pathogenesis and tyrosine dephosphorylation: surprising 'bedfellows'. Molecular Microbiology. 5: 2617-20. PMID 1723471 DOI: 10.1111/J.1365-2958.1991.Tb01970.X  0.326
1991 Bliska JB, Guan KL, Dixon JE, Falkow S. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proceedings of the National Academy of Sciences of the United States of America. 88: 1187-91. PMID 1705028 DOI: 10.1073/Pnas.88.4.1187  0.468
1990 Miller VL, Bliska JB, Falkow S. Nucleotide sequence of the Yersinia enterocolitica ail gene and characterization of the Ail protein product. Journal of Bacteriology. 172: 1062-9. PMID 1688838 DOI: 10.1128/Jb.172.2.1062-1069.1990  0.362
Show low-probability matches.